- Novo Nordisk expands in China and Czech; Cellares boosts Series D by $50MPlus more from Eisai and Siegfried. 🧱 Novo Nordisk's expansions: Novo Nordisk has invested around $380 million to expand its manufacturing facility in Bohumil, Central Bohemia, in the Czech Repu…Endpoints · 1mo ago↗ source
- Biogen adds more immune drugs in $1B buyout of secretive startup RayThera<figure><div><img src="https://imgproxy.divecdn.com/Uto2VRn61o7u_sFbw6zPAlwZMdRxZOBYNj0bVh4-oRI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9nZW5fUGhvdG9fMy5KUEc=.webp"/><…BioPharma Dive · 1mo ago↗ source
- IRA's Medicare out-of-pocket cap increased access to drugs, study findsMedication usage, particularly for the most expensive drugs, increased significantly shortly after the Medicare annual out-of-pocket cost cap took effect in January 2025, a study published in JAMA…